ACE2 and COVID-19: Since ACE2 is expressed by various tissues, including epithelial cells of the GI tract (33), GI symptoms are usual in COVID-19 and the most ordinary GI presentation in COVID-19 patients is diarrhea, followed by vomiting and/or nausea and abdominal pain (34).